Miostat Injection (Carbachol Intraocular Solution) 0.01% x 12 Vials Per Box

Bacteriostatic Water Injection by Hospira, Multiple Dose Vials 30 mL 25/Pack (Rx)
$ 539.00
IV Bags, IV Fluid Solution for Intravenous & Infusion IV Therapy (Rx)
$ 10.95
Exel IV Administration Set, Y-Injection Site, 78" Tube, Roller Clamp
$ 1.95
Bacteriostatic Sodium Chloride 0.9% Saline Injection Multiple Dose 30 ml x 25/Pack (Rx)
$ 125.00
MI Paste with Mint Flavor Remineralizing Toothpaste by GC America
$ 23.00
Mi Paste One Anti-Cavity Toothpaste, Fresh Mint by GC America
$ 24.00
Alcohol Prep Pads Sterile by Dynarex 200/Box
$ 2.49
Nitrile Powder Free Examination Gloves Blue Color, 100/Box
$ 7.95
Albuterol Sulfate 0.083% Inhalation Nebulizer Solution 2.5 mg/3 ml 25/Box (Rx)
$ 18.50
IV Set 15 Drop Luer Lock with 78" Tubing, Roller Clamp, and Y-Injection Site Ports
$ 1.99
Sale 23%
Sale 44%
🔒 Medical License Required
Sale 54%
Sale 29%
Sale 36%
🔒 Medical License Required
Sale
Sale 36%
Sale 12%
Sale 35%
🔒 Medical License Required
Sale 29%
Sale 36%
🔒 Medical License Required
Sale 28%
Sale 32%
🔒 Medical License Required
Sale 26%
🔒 Medical License Required
Sale 34%
🔒 Medical License Required
Sale 26%
🔒 Medical License Required
Sale 35%
🔒 Medical License Required
Sale 34%
Sale 15%
🔒 Medical License Required
Miostat Injection, containing 0.01% Carbachol, is an intraocular solution is designed to induce miosis during ocular surgery. Supplied in a convenient box of 12 vials, Miostat ensures precise control over intraoperative iris motion for enhanced surgical outcomes.
Miostat Injection (Carbachol Intraocular Solution) 0.01% is a leading ophthalmic pharmaceutical designed for rapid, safe, and effective induction of miosis during cataract and other anterior segment eye surgeries. Each prescription-strength box contains 12 single-use sterile vials, ensuring optimal sterility and efficacy for every procedure.
For intraocular administration by ophthalmic surgeons only. Instill the recommended dose into the anterior chamber of the eye during surgery according to surgical protocols. Not for topical or systemic use.
Miostat Injection (carbachol intraocular solution) 0.01% is FDA-approved for intraocular use during cataract surgery and other anterior segment procedures to promptly induce miosis and mitigate postoperative increases in intraocular pressure.
Clinically Trusted For:
Â
Miostat Injection, containing 0.01% Carbachol, is an intraocular solution is designed to induce miosis during ocular surgery. Supplied in a convenient box of 12 vials, Miostat ensures precise control over intraoperative iris motion for enhanced surgical outcomes.
Miostat Injection (Carbachol Intraocular Solution) 0.01% is a leading ophthalmic pharmaceutical designed for rapid, safe, and effective induction of miosis during cataract and other anterior segment eye surgeries. Each prescription-strength box contains 12 single-use sterile vials, ensuring optimal sterility and efficacy for every procedure.
For intraocular administration by ophthalmic surgeons only. Instill the recommended dose into the anterior chamber of the eye during surgery according to surgical protocols. Not for topical or systemic use.
Miostat Injection (carbachol intraocular solution) 0.01% is FDA-approved for intraocular use during cataract surgery and other anterior segment procedures to promptly induce miosis and mitigate postoperative increases in intraocular pressure.
Clinically Trusted For:
Â
Miostat (carbachol intraocular solution) is used during eye surgeries, such as cataract surgery, to quickly constrict the pupil (produce miosis) and to help lower intraocular pressure (IOP) after surgery.
Miostat is injected directly into the anterior chamber of the eye (intraocularly) by an ophthalmologist during surgery. It is not for topical or general injection use.
Pupil constriction usually occurs within minutes of injection and the effect can last for several hours.
Miostat is used to achieve rapid miosis (pupil constriction), which can help prevent complications following eye surgery and stabilize the intraocular lens.
Possible side effects include temporary eye irritation, stinging, burning, blurred vision, increased tearing, or redness.
Rare but serious effects include intraocular inflammation, persistent miosis, elevated eye pressure, or hypersensitivity reactions such as swelling or rash around the eyes.
Miostat should not be used in patients with hypersensitivity to carbachol or any component of the formulation.
Yes, it may be used in both adults and pediatric patients when indicated by an ophthalmic surgeon.
No. Miostat is approved for intraoperative use only and not for chronic or outpatient glaucoma therapy.
Follow your surgeon’s postoperative instructions. Most patients do not need to do anything specific related to Miostat, but report any unusual vision changes or discomfort right away.
Since it is used intraoperatively and not as a long-term medication, drug interactions are rare. However, always inform your surgeon about all medications and eye drops you use.
The injection is given while you are under anesthesia or local numbing, so discomfort is minimal or not felt at all.
Standard sterile techniques are used to minimize infection risk during surgery when Miostat is administered.
It should be stored at controlled room temperature and protected from light. The vial is intended for single use.
Activity restrictions are determined by your surgeon based on the type of procedure, not the Miostat itself. Always follow your surgeon’s post-op recommendations regarding driving, lifting, or using eye drops.
Something went wrong. Please try again.
Check your email for exclusive offers and updates from Mountainside Medical.
Are you sure you want to cancel your payment? Your cart is still saved.
You need an account to add products to your wishlist. Log in or create an account to start saving your favorites.
